The stock of Alphatec Holdings Inc. (NASDAQ:ATEC) last traded at $18.04, up 4.94% from the previous session.
Data from the available sources indicates that Alphatec Holdings Inc. (NASDAQ:ATEC) is covered by 9 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $32.00 and a low of $17.00, we find $19.00. Given the previous closing price of $17.19, this indicates a potential upside of 10.53 percent. ATEC stock price is now 15.28% away from the 50-day moving average and 37.59% away from the 200-day moving average. The market capitalization of the company currently stands at $2.14B.
In total, 0 analysts have assigned it a hold rating, and 9 have given it a buy rating. Brokers who have rated the stock have averaged $21.06 as their price target over the next twelve months.
With the price target of $12, Jefferies recently initiated with Buy rating for Alphatec Holdings Inc. (NASDAQ: ATEC).
In other news, Hunsaker Craig E, EVP, PEOPLE/CULTURE & GC sold 100,487 shares of the company’s stock on Jun 28. The stock was sold for $1,808,766 at an average price of $18.00. Upon completion of the transaction, the EVP, PEOPLE/CULTURE & GC now directly owns 1,120,427 shares in the company, valued at $20.21 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 27, EVP, PEOPLE/CULTURE & GC Hunsaker Craig E sold 6,542 shares of the business’s stock. A total of $117,756 was realized by selling the stock at an average price of $18.00. This leaves the insider owning 1,220,914 shares of the company worth $22.03 million. Insiders disposed of 5,486,760 shares of company stock worth roughly $98.98 million over the past 1 year. A total of 8.40% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ATEC stock. A new stake in Alphatec Holdings Inc. shares was purchased by LISANTI CAPITAL GROWTH, LLC during the first quarter worth $17,425,000. INTRINSIC EDGE CAPITAL MANAGEMENT LLC invested $11,906,000 in shares of ATEC during the first quarter. In the first quarter, GREAT LAKES ADVISORS, LLC acquired a new stake in Alphatec Holdings Inc. valued at approximately $6,747,000. NORGES BANK acquired a new stake in ATEC for approximately $5,585,000. ALTIUM CAPITAL MANAGEMENT LP purchased a new stake in ATEC valued at around $4,871,000 in the second quarter. In total, there are 247 active investors with 51.00% ownership of the company’s stock.
With an opening price of $17.36 on Monday morning, Alphatec Holdings Inc. (NASDAQ: ATEC) set off the trading day. During the past 12 months, Alphatec Holdings Inc. has had a low of $5.73 and a high of $18.59. The fifty day moving average price for ATEC is $15.71 and a two-hundred day moving average price translates $13.16 for the stock.
The latest earnings results from Alphatec Holdings Inc. (NASDAQ: ATEC) was released for Mar, 2023. According to the Medical Devices Company, earnings per share came in at -$0.4, missing analysts’ expectations of -$0.31 by -0.09. This compares to -$0.43 EPS in the same period last year. The net profit margin was -39.30% and return on equity was 581.90% for ATEC. The company reported revenue of $109.11 million for the quarter, compared to $70.93 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 53.82 percent. For the current quarter, analysts expect ATEC to generate $109.89M in revenue.
Alphatec Holdings Inc.(ATEC) Company Profile
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. It manufactures and sells implants and instruments through third-party suppliers. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform; Sigma PTP Access and Patient Positioning System; split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; EOS imaging system that provides full-body imaging; spinal implants and fixation systems; and NanoTec and Calibrate PSX, as well as various standalone implants for height restoration and stabilization. It also provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix, a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM; AlphaGRAFT Demineralized Bone Matrix comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives in the United States and internationally. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
